Patient Square Capital’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
Other funds holding MIRM
FLSM
JT
Patient Square Capital's MIRM Position: Q2 2026 in Review
Patient Square Capital increased its Mirum Pharmaceuticals (MIRM) stake by 13% in Q2 2026, buying an estimated $3.06M and bringing the position to 260,500 shares worth $30.5M. The position accounts for 4.72% of the portfolio, ranked #3.
Patient Square Capital first reported a position in MIRM in Q4 2024 and has held it in 7 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.
- Patient Square Capital held 260,500 shares of Mirum Pharmaceuticals worth $30.5M as of Q2 2026.
- Patient Square Capital bought 30,500 Mirum Pharmaceuticals shares in Q2 2026, an estimated $3.06M.
- Mirum Pharmaceuticals made up 4.72% of Patient Square Capital's portfolio in Q2 2026, its #3 holding.
- Patient Square Capital first reported a position in Mirum Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
- 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.
Based on Patient Square Capital's 13F filing for Q2 2026, filed 12 Aug 2026.